Drug resistance to acyclovir and related drugs (eg, famciclovir or valacyclovir) is rare in immunocompetent hosts, but is seen more commonly. Among immunocompetent hosts, even those who have received ) or = 6 years of continuous acyclovir, the prevalence of acyclovir-resistant isolates has remained stable at approximately 3%. Only three cases of clinical resistance of HSV to acyclovir have been reported.
It's possible, said Maurer, that long courses of acyclovir taken to prevent herpes simplex outbreaks can lead to development of drug-resistant. Acyclovir (ACV) is the drug of choice for prophylactic and curative treatment of HSV infection.
However, the emergence of ACV-resistant HSV infection is a new. Infection because of herpes simplex virus (HSV) that is resistant to acyclovir (ACV) Acyclovir.
Drug resistance. Immunocompromised host. Hematopoietic stem. When treated with antiviral agents, these patients rarely develop resistance to these drugs. In contrast immunocompromised patients might not be able to control. Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the Resistance to aciclovir is rare in people with healthy immune systems, but is more common (up to 10%) in people with immunodeficiencies on.
Significantly more index case patients had used antiviral drugs, and they Acyclovir-resistant HSV strains in apparently benzac 10 buy australia subjects. Detect herpes simplex virus (HSV) resistance to acyclovir Acyclovir Resistance HSV; Drug Resistance; Herpes Simplex Types 1 and 2 virus Phenotyping. The prevalence of acyclovir-resistant HSV in these studies ranged from 0.1 to 0.7%, with a mean of 0.3%; isolates were from patients with genital herpes (14; Reyes et al., Abstr. 11th Int. Conf.
Antiviral Res.), untreated recurrent herpes labialis (2, 8), or unspecified HSV infections (17).